These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8097551)

  • 1. Paclitaxel (taxol) for ovarian cancer.
    Med Lett Drugs Ther; 1993 May; 35(896):39-40. PubMed ID: 8097551
    [No Abstract]   [Full Text] [Related]  

  • 2. [Taxol (paclitaxel) as second-line therapy in breast and ovarian cancer].
    Borovik R; Steiner M; Atad J; Sneiderman B; Rosenberg T; Palti S
    Harefuah; 1998 Apr; 134(8):605-8, 671. PubMed ID: 10911422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Taxol in the treatment of ovarian neoplasm].
    Wang Y; Huang R; Huang H
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):439-41. PubMed ID: 11360659
    [No Abstract]   [Full Text] [Related]  

  • 4. What you need to know about Taxol.
    Lilley LL; Scott HB
    Am J Nurs; 1993 Dec; 93(12):46-50. PubMed ID: 7905707
    [No Abstract]   [Full Text] [Related]  

  • 5. [Paclitaxel (Taxol)--drug of choice in ovarian cancer].
    Fishman A
    Harefuah; 1996 Apr; 130(8):557-60. PubMed ID: 8765885
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new cytostatic agent: Taxol].
    Uitterhoeve RJ
    TVZ; 1994 Apr; 104(7):223-6. PubMed ID: 7915524
    [No Abstract]   [Full Text] [Related]  

  • 7. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel in platinum-resistant ovarian cancer patients. Argentine Multicenter Taxol Group.
    Ezcurdia L; Jovtis SL; Mickiewicz E; Temperley G; Rondinón M; Blajman C; Cóppola FS; Lewi D; Cazap E; Breier S; Fasce H; Fein L; Polera J; Triguboff E; Uranga G; Pasccón G; Luchina AM; Martínez CA; Politi PM; Rubio G; Alvarez AM
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-53-S15-56. PubMed ID: 9346223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Taxol].
    Kühnle H
    Zentralbl Gynakol; 1996; 118(10):580. PubMed ID: 8999717
    [No Abstract]   [Full Text] [Related]  

  • 10. Paclitaxel (taxol).
    Rowinsky EK; Donehower RC
    N Engl J Med; 1995 Apr; 332(15):1004-14. PubMed ID: 7885406
    [No Abstract]   [Full Text] [Related]  

  • 11. [Taxol--a novel experimental drug for the treatment of ovarian cancer].
    Menczer J
    Harefuah; 1993 Jan; 124(1):28-30. PubMed ID: 8094702
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy of ovarian and breast cancer with Taxol].
    Dtsch Med Wochenschr; 1996 Dec; 121(50 Suppl):1-12. PubMed ID: 9022362
    [No Abstract]   [Full Text] [Related]  

  • 13. NICE approves Taxol for ovarian cancer.
    Kmietowicz Z
    BMJ; 2000 May; 320(7245):1293. PubMed ID: 10807610
    [No Abstract]   [Full Text] [Related]  

  • 14. [Second-line chemotherapy for ovarian cancer: the potential of Taxol].
    Maksimov SIa
    Vopr Onkol; 2002; 48(1):99-101. PubMed ID: 12101579
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypersensitivity reactions in paclitaxel treatment of ovarian cancer patients.
    Lehoczky O; Bagaméri A; Udvary J; Pulay T
    J Obstet Gynaecol; 2002 May; 22(3):312-3. PubMed ID: 12521509
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status and future directions of platinum/paclitaxel-based chemotherapy of ovarian cancer.
    Markman M
    Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-24-S11-27. PubMed ID: 9314295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxol--new hope for cancer patients.
    Fox SM; Haney LG
    RN; 1994 Nov; 57(11):33-6. PubMed ID: 7984878
    [No Abstract]   [Full Text] [Related]  

  • 18. A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.
    Pignata S; Breda E; Scambia G; Pisano C; Zagonel V; Lorusso D; Greggi S; De Vivo R; Ferrandina G; Gallo C; Perrone F
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):229-36. PubMed ID: 18243011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxol hypersensitivity: rapid retreatment is safe and cost effective.
    Olson JK; Sood AK; Sorosky JI; Anderson B; Buller RE
    Gynecol Oncol; 1998 Jan; 68(1):25-8. PubMed ID: 9454655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor lysis syndrome associated with weekly paclitaxel treatment in a case with ovarian cancer.
    Yahata T; Nishikawa N; Aoki Y; Tanaka K
    Gynecol Oncol; 2006 Nov; 103(2):752-4. PubMed ID: 16857250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.